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which adipose tissue infl uences organismal substrate dis-
tribution and metabolism in both physiological and 
pathophysiological states. Recently, the unexpected obser-
vation was made that the endogenous expression of apoE 
in adipose tissue and adipocytes importantly infl uences 
adipocyte differentiated function. Adipocytes that do not 
express endogenous apoE are smaller, contain less lipid, 
display a defect in lipogenesis and substrate acquisition 
from extracellular lipoproteins, and have alterations in 
the expression of genes controlling adipocyte lipid turn-
over ( 4–7 ). Moreover, these defects cannot be corrected 
by the provision of extracellular apoE in vitro or in vivo, 
but can be corrected by adenoviral-mediated expression 
of endogenous apoE in adipocytes ( 4, 5 ). Because of these 
effects on adipose tissue metabolism, endogenous adipo-
cyte apoE also importantly infl uences the systemic distri-
bution of substrate in intact animals ( 5 ). A physiological 
role for endogenous adipocyte apoE expression in the 
regulation of organismal metabolism is further under-
scored by the recent demonstration of physiologically rel-
evant pathways for regulating adipocyte apoE expression 
( 8–14 ). 
 In humans, apoE is a polymorphic protein, and three 
common isoforms have been identifi ed: apoE2 (Cys 112 /
Cys 158 ), apoE3 (Cys 112 /Arg 158 ), and apoE4 (Arg 112 /Arg 158 ). 
The apoE3 isoform is by far the most common and is pres-
ent in more than 75% of individuals. The presence of the 
apoE2 or apoE4 isoform has been associated with impor-
tant human diseases and alterations in systemic lipopro-
tein metabolism ( 15–17 ). There are also observations in 
human populations suggesting a relationship between 
apoE isoform expression and adiposity, and a relationship 
between adiposity and lipid metabolism ( 18, 19 ). In addi-
tion, important differences in cellular turnover of the 
apoE isoforms, with related implications for differentiated 
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After 8 weeks, transplanted adipose tissue was harvested. Adipo-
cyte surface area in transplanted adipose tissue was measured 
using ImageScope (Aperio Technologies; Vista, CA) in paraffi n-
embedded adipose tissue sections stained with hematoxylin-
eosin. For each transplanted adipose tissue genotype, a minimum 
of 800 cells were evaluated. 
 Quantitation of apoE protein and mRNA 
 ApoE protein and mRNA levels in adipocytes were analyzed as 
described previously ( 4, 6 ). Briefl y, adipocyte lysates were sepa-
rated by electrophoresis, transferred to nitrocellulose mem-
branes, and incubated with goat anti-human apoE antiserum. 
ApoE signals were quantifi ed by Image Quant TL v2005 software 
(GE Healthcare; Piscataway, NJ). Flotillin-2 was used for loading 
normalization. 
 Total RNA was extracted from adipocytes, macrophages, or liv-
ers using the Qiagen RNeasy kit (Valencia, CA). First-strand 
cDNA was synthesized according to the manufacturer’s instruc-
tions (Fermantas; Hanover, MD). Real-time PCR was performed 
in triplicate using Brilliant SYBR Green QRT-PCR Master Mix II 
on Stratagene MX 3000P (Agilent Technologies; La Jolla, CA). 
Primers have been previously described ( 4, 6 ). PCR conditions 
were 95°C for 1 min (1 cycle), followed by 94°C for 30 s, 61°C for 
30 s, and 72°C for 30 s (40 cycles). Data were analyzed using com-
parative critical threshold (Ct), normalized to   -actin, and were 
calculated by 2–   Ct. 
 Analysis of adipocyte apoE synthesis and turnover 
 Cultured adipocytes were pulse-labeled with 200   Ci/ml  35 [S]
methionine in DMEM (methionine-free) for 45 min, followed by 
60 min chase in DMEM containing 500   M unlabeled methion-
ine. Biosynthetically labeled apoE in the cell and medium was 
measured as previously described ( 34, 35 ). Briefl y, cell lysates 
and culture medium were immunoprecipitated with a goat anti-
human apoE antibody. Immune complexes were then pulled 
down with recombinant protein G agarose beads. ApoE was 
eluted from the beads by boiling in sample buffer, followed by 
electrophoresis on 10% SDS-PAGE gel. Labeled apoE was quan-
titated using Image Quant TL v2005 software (Amersham Biosci-
ences; Piscataway, NJ). ApoE synthesis was measured as the level 
of biosynthetically labeled apoE present in cell lysates after a 
45 min pulse and no chase incubation. Secreted apoE was measured 
as labeled apoE in the medium after a 60 min chase incubation. 
Retained apoE was measured as labeled apoE in cell lysates after 
a 60 min chase incubation. ApoE degradation was calculated by 
subtracting secreted and retained apoE (at 60 min chase) from 
total synthesized cellular apoE present at the start of the chase 
incubation ( 34, 35 ). 
 VLDL isolation 
 Human VLDL was isolated from plasma as previously described 
( 4, 6 ). The apoE genotype for plasma donors was determined by 
PCR as described ( 36, 37 ). The VLDL preparations used in this 
series of experiments were obtained from E3/E3 donors. 
 Adipocyte TG synthesis and hydrolysis 
 To measure adipocyte TG synthesis, adipocytes were incubated 
with 0.5   Ci/ml  14 [C]glucose with or without 100   g/ml VLDL 
in DMEM (5 mM glucose) and 0.1% BSA for 6 h. Cells were 
washed, and lipids were extracted. TG was separated by TLC in a 
solvent system of hexane-ethyl ether-acetic acid (90:30:1) as pre-
viously described ( 6 ). TG spots were visualized and harvested, 
and the radioactivity of the spots was measured in a scintillation 
counter. TG hydrolysis was estimated by measuring the release of 
glycerol into incubation medium over 2 h ( 6 ). 
cell function, have been described in macrophages ( 20–23 ) 
and neuronal cells ( 24–26 ). For example, in macrophages, 
the secretion of apoE2 is impaired, and there is an associ-
ated alteration in macrophage sterol effl ux mediated by 
apoE2. In vivo, adipose tissue dysfunction has been associ-
ated with the systemic expression of apoE4 in mice main-
tained on a high-fat Western diet ( 27, 28 ). 
 In view of these considerations, in the current stud-
ies, we have evaluated the impact of apoE isoform ex-
pression in adipocytes on adipocyte function by taking 
advantage of the previously described human apoE2, 
apoE3, and apoE4 knock-in mouse models. In these 
mice, mouse apoE expression is deleted and replaced 
with expression of the human apoE2, -E3, and -E4 iso-
forms under the control of endogenous gene control 
elements. Using adipose tissue and adipocytes isolated 
from these mice, we have characterized adipocyte han-
dling of the apoE isoforms and have evaluated the im-
pact of apoE2 isoform expression on adipocyte lipid 
metabolism. 
 MATERIALS AND METHODS 
 Materials 
 Cell culture medium and FBS were purchased from Invitrogen 
(Carlsbad, CA). Organic solvents were from Thermo-Fisher 
(Pittsburgh, PA). Other chemicals were from Sigma (St. Louis, 
MO).  35 [S]methionine and  14 [C]glucose were obtained from 
PerkinElmer (Wellesley, MA). Triglyceride (TG) assay kits were 
obtained from Wako Chemicals USA (Richmond, VA). The 
Quencher based technology (QBT) assay kit was obtained from 
Molecular Devices (Sunnyvale, CA). Other reagents were from 
previously identifi ed sources ( 4–14 ). 
 Animals and cell isolation and culture 
 C57BL/6 mice were knocked in with human apoE2, -E3, or -E4 
alleles to replace native mouse apoE. These models have been 
described in detail in previous publications ( 29–33 ). In these 
mice, expression of the apoE isoform remains under the control 
of the endogenous apoE gene control elements. All animal 
protocols in this study were approved by the Institutional 
Animal Care and Use Committees of the University of Illinois at 
Chicago. 
 Intra-abdominal perigonadal adipose tissue was collected 
from age- (12–14 week-old) and gender-matched apoE2, -E3, 
and -E4 isoform knock-in mice. Mature adipocytes were iso-
lated by collagenase digestion of adipose tissues, as previously 
described in detail ( 4, 6 ). The diameter of freshly isolated ma-
ture adipocytes was determined as previously described ( 5 ). 
Preadipocytes were isolated from the adipose tissue stromovas-
cular fraction, differentiated to mature adipocytes, and main-
tained in culture for 10–14 days, also as previously described 
( 4, 6 ). Adipose tissue explants and culture were prepared as 
described ( 4, 6 ). Mouse macrophages were collected after 
peritoneal cavity lavage with cold PBS. Macrophages were 
washed and cultured in DMEM and 10% FBS for 10–14 days as 
previously described ( 34 ). 
 For adipose tissue transplantation experiments, adipose tissue 
harvested from 10 week-old apoE2 isoform mice was transplanted 
into 14 week-old apoE2 or apoE3 isoform recipient mice (n = 5 for 
each recipient isoform type) as previously described in detail ( 5 ). 
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gene expression, apoE synthesis, and cellular apoE turn-
over in adipocytes isolated from apoE2, -E3, and -E4 
knock-in mice.  Figure 1  shows apoE mRNA levels in 
freshly isolated mature adipocytes, cultured adipocytes, 
liver, and mouse peritoneal macrophages harvested 
from the apoE isoform mice. ApoE2 mRNA levels are 
substantially elevated in fresh and cultured adipocytes 
compared with apoE3 and apoE4 isoforms. There is no 
such elevation observed in liver or macrophages.  Figure 2 
 shows results of a Western blot analysis of apoE protein 
levels in freshly isolated mature and cultured adipocytes. 
ApoE protein levels are signifi cantly elevated in adipo-
cytes expressing the apoE2 isoform, compared with adi-
pocytes expressing the E3 and E4 isoforms. The large 
increment in apoE mRNA levels, compared with a 
smaller, but still signifi cant increase in protein levels for 
apoE2, suggested differences in posttranslational pro-
cessing of the apoE2 isoform. This was examined more 
carefully using pulse-chase analysis in cultured adipo-
cytes. First, the synthesis of the apoE isoforms was evalu-
ated by pulse-labeling cells for 45 min and evaluating the 
amount of labeled apoE present in cell lysates. As shown 
in  Fig. 3A , the synthetic rate of apoE2 was elevated ap-
proximately 2.5-fold compared with apoE3 and apoE4. 
Using a 45 min pulse-labeling followed by a 60 min chase, 
we directly measured apoE secretion and cellular reten-
tion, and calculated degradation rate for newly synthesized 
apoE as described in Materials and Methods.  Figure 3B 
 Adipocyte FA uptake 
 FA uptake by adipocytes was measured using the QBT FA up-
take assay kit according to the manufacturer’s instructions ( 6 ). 
The kit uses a biodipy-dodecanoic FA fl uorescent analog that re-
mains quenched until taken up by cells. Mature adipocytes were 
incubated with 400   M oleic acid (FA:BSA molar ratio = 2:1) 
along with QBT FA uptake solution. Readings of FA uptake were 
recorded over a period of 15 min using a Synergy HT multimode 
plate reader (BioTek; Winooski, VT). 
 Lipid, protein, and DNA estimations 
 TG levels were quantitated using a kit from Wako Chemicals. 
DNA was isolated with Qiagen DNeasy kit according to the manu-
facturer’s instructions. The amount of DNA was measured by a 
PicoGreen DNA assay kit (Invitrogen; Carlsbad, CA). Cell pro-
tein was measured using a detergent compatible (DC) protein 
assay kit (Bio-Rad; Hercules, CA). 
 Statistical analysis 
 The results are expressed as mean ± SD of triplicate determi-
nations for each group unless indicated in the fi gure legends. 
Results presented are representative of two or three experiments. 
Statistical differences were analyzed by Student  t -test or ANOVA 
using SPSS 17.0 (Chicago, IL) or Microsoft Excel.  P < 0.05 was 
considered signifi cant. 
 RESULTS 
 Regulation of apoE genes in these knock-in mice remains 
under the control of endogenous apoE gene regulatory 
elements ( 29–33 ). We, therefore, fi rst evaluated level of 
 Fig.  1. ApoE mRNA levels in adipocytes, macrophages, and liver of apoE isoform knock-in mice. RNA was 
isolated from (A) freshly isolated mature adipocytes, (B) adipocytes differentiated from preadipocytes and 
maintained in culture, (C) liver, or (D) peritoneal macrophages of apoE knock-in mice. ApoE mRNA levels 
were analyzed by quantitative RT-PCR as described in Materials and Methods. The results are from fi ve mice 
per group, and each sample was analyzed in triplicate. ** P < 0.01 compared with apoE3. 
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larger size adipocytes; this shift was refl ected in a higher 
mean adipocyte diameter ( Fig. 4B ) compared with apoE3 
and apoE4 mice. 
 Changes in adipocyte size and overall body fat mass in 
apoE2 mice could result from increased circulating 
lipid and apoE levels, noted in  Table 1 . However, a role 
for endogenous adipocyte apoE in regulating adipocyte 
size and overall body fat mass, independent of circulat-
ing lipid levels, has been established ( 4–6 ). We, there-
fore, directly examined the impact of apoE isoform 
expression on adipocyte lipid metabolism in adipocytes 
isolated from apoE isoform mice. We have previously 
shown that in apoE knockout (EKO) adipocytes, TG 
synthesis is lower in both the presence and the absence 
of extracellular VLDL, and that TG hydrolysis is higher 
( 6 ).  Figure 5A  shows that adipocytes expressing the 
apoE2 isoform synthesized signifi cantly less TG in both 
the absence and the presence of extracellular apoE3/E3 
VLDL compared with apoE3 adipocytes.  Figure 5B shows 
that TG hydrolysis, as measured by release of glycerol to 
the extracellular medium over 2 h, was elevated in adi-
pocytes expressing apoE2, compared with those express-
ing apoE3. Therefore, despite signifi cantly expanded 
apoE synthesis and increased cellular levels of the 
apoE2 isoform, adipocytes expressing this isoform dem-
onstrate TG turnover characteristics similar to those ob-
served in EKO adipocytes, and as previously observed in 
EKO adipocytes, the defect in TG synthesis is maintained 
shows that secretion of both apoE2 and apoE4 were sig-
nifi cantly lower than that measured for the apoE3 iso-
form. ApoE2 retention in the cell was also signifi cantly 
lower than that of both apoE3 and apoE4. The largest 
difference between the isoforms was for degradation 
rate of newly synthesized apoE2, which was substantially 
elevated, compared with degradation rates observed for 
both apoE3 and apoE4. These results indicate that newly 
synthesized apoE2 in adipocytes is highly unstable and 
undergoes rapid degradation prior to its secretion. The 
reduction in apoE4 secretion is related to smaller 
changes in both retention and degradation, compared 
with apoE3. 
 We next evaluated the impact of apoE isoform expres-
sion on adipocyte TG metabolism.  Table 1  presents results 
for plasma lipid levels, body weight, and gonadal fat pad 
weight in the apoE isoform knock-in mice. The plasma to-
tal cholesterol and TG were signifi cantly higher in apoE2 
mice compared with apoE3 and apoE4 mice. There was no 
difference in circulating FFA level. It has already been re-
ported that circulating apoE levels in apoE2 mice are sig-
nifi cantly elevated (up to 16-fold) compared with apoE3 
mice ( 31 ). Total body weight was not different among the 
three types of mice. However, gonadal fat pad weight was 
signifi cantly higher in the apoE2 isoform mice.  Figure 4  
further explores the signifi cance of this change in gonadal 
fat pad weight by presenting size distribution for mature 
adipocytes isolated from the gonadal fat pad of apoE2, apoE3, 
and apoE4 isoform mice. As shown in  Fig. 4A , compared with 
apoE3 and apoE4 mice, apoE2 mice demonstrated altered 
distribution in overall adipocyte diameter with a shift to 
 Fig.  2. ApoE protein levels in freshly isolated mature and cul-
tured adipocytes from apoE isoform knock-in mice. A: Freshly iso-
lated mature adipocytes isolated from the perigonadal fat pad or 
(B) adipocytes cultured from preadipocytes isolated from the same 
depot and maintained in culture were utilized for Western blot for 
apoE as described in Materials and Methods. * P < 0.05, ** P < 0.01 
compared with apoE3. 
 Fig.  3. ApoE synthesis and turnover in adipocytes from apoE iso-
form knock-in mice. A: Cultured adipocytes were pulse-labeled 
with 200   Ci/ml  35 [S]methionine for 45 min and immediately har-
vested to measure incorporation of label into newly synthesized cel-
lular apoE. B: Cultured adipocytes were pulse-labeled as described 
above followed by a 60 min chase incubation in DMEM supple-
mented with 500   M unlabeled methionine. The amount of apoE 
secreted and retained in cells was directly measured, and the 
amount degraded was calculated as described in Materials and 
Methods. * P < 0.05, ** P < 0.01 for comparison to apoE3. 
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incubation in VLDL, however, signifi cantly increases TG 
mass in E3 and E4 adipose tissue. TG mass does not in-
crease, and appears to decrease, in E2 adipose tissue incu-
bated with VLDL. This result in intact adipose tissue is 
consistent with results in isolated cells showing that E2 adi-
pocytes manifest impaired lipogenesis in response to 
VLDL compared with E3 and E4 adipocytes. 
 The defect in lipogenesis in apoE2-expressing adipo-
cytes would predict the presence of smaller adipocytes. 
However, freshly isolated mature adipocytes from E2 mice 
are signifi cantly larger (by about 15%) compared with adi-
pocytes harvested from E3 or E4 isoform mice ( Fig. 4 ). 
The results shown in  Figs. 5 and 6 implicate the chronic 
hyperlipidemia resulting from systemic expression of 
apoE2 as the driver of larger adipocyte size in apoE2 iso-
form mice. To more directly evaluate this question, we 
transplanted adipose tissue from hyperlipidemic apoE2 
isoform mice into normolipidemic apoE3 isoform mice. 
For a control, we also transplanted apoE2 adipose tissue 
into apoE2 recipient mice. After 8 weeks in the normolipi-
demic E3 in vivo milieu, the surface area of the trans-
planted E2 adipocytes decreased by 16% ( P < 0.02) 
compared with E2 adipocytes transplanted into hyperlipi-
demic E2 recipients (not shown). This result supports the 
importance of chronic hyperlipidemia for driving larger 
adipocyte size in E2 isoform mice. 
 In EKO adipocytes, it has been demonstrated that the 
defect in TG synthesis is related to impaired uptake of 
the FFA released by LPL-mediated hydrolysis of TG pres-
ent in extracellular VLDL particles ( 6 ). We analyzed this 
mechanism for the defect in TG synthesis observed in E2 
cells.  Figure 7A  examines the importance of LPL-mediated 
hydrolysis of VLDL for producing the difference in TG 
synthesis between apoE isoform adipocytes by utilizing 
the LPL inhibitor, tetrahydrolipstatin (THL). In the 
presence of VLDL, but the absence of THL, TG synthesis 
is signifi cantly lower in the apoE2 isoform adipocytes 
(consistent with results shown in  Fig. 5A ). In the pres-
ence of THL, TG synthesis is substantially suppressed in 
each of the apoE isoform adipocytes, and there are no 
longer signifi cant differences between them, suggesting 
that LPL-mediated hydrolysis of VLDL contributed to the 
difference in TG synthesis observed between apoE2 and 
apoE3 adipocytes. To determine whether this result 
could be explained by differences in LPL expression, we 
directly measured total and secreted LPL activity in the 
apoE isoform adipocytes.  Figure 7B shows that total li-
polytic activity, as well as secreted lipolytic activity, was 
identical in the apoE2, apoE3, and apoE4 adipocytes. 
Therefore, differences in LPL expression cannot account 
despite the provision of extracellular apoE3 in VLDL 
particles. 
 To further confi rm differences in VLDL-mediated lipo-
genesis in the context of intact adipose tissue, we next ex-
amined the impact of incubating perigonadal fat isolated 
from apoE2, apoE3, and apoE4 mice with apoE3/E3 VLDL 
on TG mass. After 24 h incubation in the absence of VLDL, 
there was no signifi cant difference in adipose tissue TG 
mass comparing the apoE isoform adipose tissue types, 
although this level tended to be somewhat higher in 
E2 compared with E3 and E4 adipose tissue  ( Fig. 6 ). A 24 h 
 TABLE 1. Plasma lipids, body weight, and perigonadal fat mass in apoE knock-in mice 
TC TG FFA Body Weight Fat Pad 
 mg/dl  mg/dl  mmol/dl  g  g 
E2 162 ± 24 a 117 ± 36 a 67 ± 16 19.9 ± 2.6 0.23 ± 0.08 a 
E3 30 ± 12 70 ± 20 65 ± 12 20.2 ± 1.1 0.13 ± 0.06
E4 24 ± 10 51 ± 16 78 ± 26 19.3 ± 2.6 0.14 ± 0.05
 a   P < 0.05 versus apoE3. TC, total cholesterol.
 Fig.  4. Adipocyte size in apoE isoform knock-in mice. Mature 
adipocytes were freshly isolated from the perigonadal fat pad of 
fi ve apoE isoform mice of each genotype as described in Materials 
and Methods. A: Adipocyte diameter was measured as described in 
Materials and Methods. B: Mean adipocyte diameter. * P < 0.05 
compared with apoE3 
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there are isoform-specifi c differences in the posttransla-
tional processing of apoE. 
 In the current set of studies, we establish that the ex-
pression of the apoE2 isoform under the control of its 
endogenous gene control elements has a signifi cant im-
pact on adipocyte apoE synthesis and degradation. In 
vivo, we demonstrate that systemic expression of the 
apoE2 isoform leads to a perturbation in adipocyte size 
distribution and a small but signifi cant increase in mean 
diameter of freshly isolated mature adipocytes. This re-
sult could have been related to the disordered systemic 
lipoprotein metabolism and hyperlipidemia associated 
with systemic expression of the apoE2 isoform. Alterna-
tively, this result could have been related to an adipocyte-
specifi c effect of endogenous apoE2 expression, based 
on previously reported observations establishing a role 
for endogenous adipocyte apoE in supporting adipocyte 
substrate acquisition and lipogenesis. The results in this 
manuscript establish that the adipocyte-specifi c effects of 
the endogenous expression of the apoE2 isoform cannot 
account for the increased adipocyte size or lipid content 
in the intact E2-expressing mouse; and adipocyte-specifi c 
effects of expression of this isoform would actually pre-
dict the presence of smaller adipocytes and less adipose 
tissue. Expression of the apoE2 isoform in adipocytes is 
associated with defective lipogenesis, compared with ex-
pression of the E3 isoform, and it is important to empha-
size that this decreased lipogenesis cannot be ascribed to 
reduced apoE2 secretion with subsequent lack of extra-
cellular apoE, inasmuch as it remains decreased even in 
the presence of apoE-containing VLDL. Further, the 
transplantation of adipose tissue from hyperlipidemic 
apoE2 mice into normolipidemic apoE3 mice leads to a 
signifi cant decrease in adipocyte size. Therefore, in 
apoE2 mice, the presence of larger adipocytes and in-
creased adipose tissue probably results from the disor-
dered lipoprotein metabolism accompanying systemic 
for the result shown in  Fig. 7A . The adipocyte lipogenesis 
that results from LPL hydrolysis of extracellular VLDL 
depends on adipocyte internalization of the released 
FFA. We, therefore, next measured the internalization of 
FFA directly. FA internalization was not different between 
apoE3 and apoE4 adipocytes; however, it was markedly 
reduced in apoE2 adipocytes ( Fig. 7C ). This result indi-
cates that a defect in the internalization of FAs released 
by LPL hydrolysis of VLDL contributes to the impaired 
lipogenesis in apoE2 adipocytes incubated with VLDL. 
This defect is identical to that observed in EKO adipo-
cytes ( 6 ). 
 DISCUSSION 
 Recently, an important role has been established for 
endogenous adipocyte apoE expression, separate from 
circulating (using in vivo experimental systems) and ex-
tracellular apoE (using in vitro experimental systems), 
for regulating adipocyte substrate metabolism ( 4–7 ). 
There are three common apoE isoforms in human popu-
lations, with apoE3 being the most common. Human ex-
pression of the apoE2 and E4 isoforms has been associated 
with important human diseases ( 15–17 ). Isoform-specifi c 
effects on cellular-differentiated function have been 
established for neurons and macrophages ( 20–26 ), and 
 Fig.  5. TG turnover in apoE isoform knock-in adipocytes. A: TG 
synthesis was measured in apoE2, -E3, and -E4 freshly isolated ma-
ture adipocytes in the absence or presence of 100   g/ml human 
VLDL isolated from an apoE3/E3 donor, as described in Materials 
and Methods. B: TG hydrolysis was measured in freshly isolated 
mature adipocytes isolated from apoE isoform mice as described in 
Materials and Methods. * P < 0.05, ** P < 0.01 for comparison to E3 
under the same incubation conditions. 
 Fig.  6. Effect of incubation with VLDL on TG mass in adipose 
tissue explants from apoE isoform knock-in mice. ApoE2, -E3, or -E4 
perigonadal adipose tissue explants were prepared and incubated 
with human VLDL (100   g/ml) harvested from an apoE3/E3 
donor in 0.2% BSA for 24 h. After incubation, TG mass was 
measured. * P < 0.05 for the change in TG mass due to inclusion of 
VLDL. 
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 Fig.  7. LPL activity and FA internalization in apoE 
isoform knock-in adipocytes. A: Mature adipocytes 
were freshly isolated from perigonadal fat pads of 
apoE isoform mice, and TG synthesis was measured 
over 6 h during incubation with 100   g/ml VLDL 
isolated from an apoE3/E3 donor with or without 
the LPL inhibitor THL. B: Total LPL activity was 
measured from mature apoE isoform knock-in adi-
pocytes. The insert shows secreted LPL activity. C: 
FA uptake was measured in freshly isolated mature 
apoE isoform adipocytes as described in Materials 
and Methods. A representative measurement of up-
take from triplicate samples is shown as a function of 
time. The inset shows total FA uptake mean ± SD 
over the monitoring period from two separate ex-
periments, each performed in triplicate using freshly 
isolated mature adipocytes pooled from fi ve mice. 
* P < 0.05, ** P < 0.01 for comparison to E3 adipo-
cytes under the same incubation conditions. 
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apoE2 expression, with attendant hyperlipidemia and in-
creased availability of circulating lipogenic substrate. 
 The defect in adipocyte apoE2 secretion and the in-
stability of the newly synthesized apoE2 isoform have 
also been reported in macrophages ( 21 ). We were sur-
prised, however, by the increase in apoE gene expres-
sion and synthesis that accompanied expression of the 
apoE2 gene under control of its endogenous control el-
ements. A number of physiologically relevant stimuli 
and regulatory pathways have been established for regu-
lation of adipocyte apoE gene expression ( 8–14 ). These 
include pathways that impact on functional LXR, 
PPAR  , and NF  B response elements identifi ed within 
apoE gene-regulatory sequences. We speculate that the 
large increase in apoE2 gene expression may relate to 
altered adipocyte lipid metabolism in E2 adipocytes, 
with defective generation of a bioactive lipid that func-
tions in a regulatory feedback loop at one of these regu-
latory sequences. This conceptual construct will require 
additional investigation. 
 It is also of interest that a major contributor to defective 
VLDL-mediated lipogenesis in adipocytes expressing the 
apoE2 isoform is ineffective internalization of FA sub-
strate. This is the precise defect identifi ed in the ineffec-
tive lipogenesis measured in EKO adipocytes, and in these 
cells appears to be related to alterations in caveolin func-
tion ( 4, 7 ). By comparing EKO and wild-type adipocytes, 
we have previously established that endogenous expres-
sion of adipocyte apoE has an important impact on adipo-
cyte caveolin expression and caveolar number ( 7 ). Further, 
endogenously synthesized adipocyte apoE can be colocal-
ized with caveolin at the adipocyte cell surface ( 7 ). Altera-
tions in secondary structure and stability of the apoE2 
isoform may lead to a defect in establishing these associa-
tions with caveolin. The experimental examination of this 
question by comparing E2, E3, and E4 isoform adipocytes, 
however, is importantly confounded by the signifi cant ex-
pansion of adipocyte apoE2 level. 
 In summary, in this manuscript, we establish that ab-
normalities in adipose tissue mass and adipocyte size 
that accompany the systemic expression of the apoE2 
isoform cannot be ascribed to adipocyte-specifi c effects 
of this isoform on adipocyte lipid metabolism, and most 
likely result from long-term exposure to elevated circu-
lating TG and apoE levels. Importantly, we also estab-
lish that gene expression and posttranslational handling 
of the apoE2 isoform are signifi cantly different from 
those of the apoE3 and apoE4 isoforms. Expression of 
the apoE2 isoform is also associated with signifi cant 
changes in adipocyte TG synthesis, TG hydrolysis, and 
FA internalization. Interpretation of human studies de-
scribing metabolic changes in apoE2, apoE3, and apoE4 
subjects will need to account for adipocyte- and adipose 
tissue-specifi c effects of the apoE isoforms when consid-
ering pathophysiological pathways accounting for these 
changes.  
 The authors thank Stephanie Thompson for assistance with 
manuscript preparation. 
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